KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Non-Current Assets (2016 - 2025)

Fulgent Genetics' Non-Current Assets history spans 10 years, with the latest figure at $663.0 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 23.47% year-over-year to $663.0 million; the TTM value through Dec 2025 reached $2.9 billion, down 15.07%, while the annual FY2025 figure was $663.0 million, 23.47% down from the prior year.
  • Non-Current Assets for Q4 2025 was $663.0 million at Fulgent Genetics, down from $707.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $907.2 million in Q3 2024 and bottomed at $339.9 million in Q1 2021.
  • The 5-year median for Non-Current Assets is $764.6 million (2022), against an average of $728.2 million.
  • The largest annual shift saw Non-Current Assets soared 1025.49% in 2021 before it fell 23.47% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $666.8 million in 2021, then rose by 13.71% to $758.2 million in 2022, then decreased by 4.05% to $727.5 million in 2023, then increased by 19.09% to $866.4 million in 2024, then dropped by 23.47% to $663.0 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Non-Current Assets are $663.0 million (Q4 2025), $707.2 million (Q3 2025), and $771.1 million (Q2 2025).